Opinion

Video

Future of MF

Experts discuss how treatments, either monotherapy or combination, may impact the treatment landscape for MF and how they might choose among the new agents.

Related Videos
Ben Levy, MD, and Yan Leyfman, MD
Aaron Gerds, MD
BTK Inhibitors in CLL : Second Generation Drugs and Beyond
Carrie L. Kitko, MD
Lori A. Leslie, MD
Naseema Gangat, MBBS
Ashwin Kishtagari, MD
Somedeb Ball, MBBS
Lori A. Leslie, MD
Changchun Deng, MD, PhD